Cookies?
Library Header Image
LSE Research Online LSE Library Services

Rapid diagnostic tests for dengue would reduce hospitalizations, healthcare costs and antibiotic prescriptions in Spain: a cost-effectiveness analysis

Camprubí-Ferrer, Daniel, Ramponi, Francesco, Balerdi-Sarasola, Leire, Godoy, Ana, Sicuri, Elisa ORCID: 0000-0002-2499-2732 and Muñoz, José (2023) Rapid diagnostic tests for dengue would reduce hospitalizations, healthcare costs and antibiotic prescriptions in Spain: a cost-effectiveness analysis. Enfermedades Infecciosas y Microbiologia Clinica. ISSN 0213-005X

[img] Text (Rapid diagnostic tests for dengue would reduce hospitalizations, healthcare costs and antibiotic prescriptions in Spain) - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (547kB)
Identification Number: 10.1016/j.eimc.2022.12.009

Abstract

Background: Current gold standard diagnostic techniques for dengue are expensive and time-consuming. Rapid diagnostic tests (RDTs) have been proposed as alternatives, although data about their potential impact in non-endemic areas is scarce. Methods: We performed a cost-effectiveness analysis comparing the costs of dengue RDTs to the current standard of care for the management of febrile returning travelers in Spain. Effectiveness was measured in terms of potential averted hospital admissions and reduction of empirical antibiotics, based on 2015–2020 dengue admissions at Hospital Clinic Barcelona (Spain). Results: Dengue RDTs were associated with 53.6% (95% CI: 33.9–72.5) reduction of hospital admissions and were estimated to save 289.08–389.31€ per traveler tested. Moreover, RDTs would have avoided the use of antibiotics in 46.4% (95% CI: 27.5–66.1) of dengue patients. Discussion: Implementation of dengue RDTs for the management of febrile travelers is a cost-saving strategy that would lead to a reduction of half of dengue admissions and a reduction of inappropriate antibiotics in Spain.

Item Type: Article
Official URL: https://www.sciencedirect.com/journal/enfermedades...
Additional Information: © 2023 The Author(s)
Divisions: LSE Health
Subjects: R Medicine > RA Public aspects of medicine
R Medicine > RM Therapeutics. Pharmacology
Date Deposited: 15 Feb 2023 00:24
Last Modified: 02 Dec 2024 17:06
URI: http://eprints.lse.ac.uk/id/eprint/118176

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics